Naresh Chouhan

Naresh Chouhan

Naresh started his career in GSK’s Corporate Development team conducting Merger modelling, Biotech screens and worked on strategic transactions. He moved to JPMorgan on the sell-side in 2006 to cover Pan-Euro Large cap Pharma. He also spent time at HSBC and 6 years as the Head of Healthcare research at Liberum. Naresh founded Intron Health in 2016 and helped drive significant growth of the franchise despite Mifid II.

Dominic Rose

Dominic Rose

Dominic has nine years’ experience in the market having joined the M&G Investment Graduate Scheme in 2012. In 2015, he joined Liberum as a  healthcare equity analyst and moved to Intron Health in 2016 to help set up the new Healthcare team, where he remains today. Dominic holds an MA degree in Natural Sciences from Cambridge University and is also a CFA charterholder.

IMG_8128

David Crawley

David has over 30 years experience in healthcare, most recently at Citi where he held a number of sales and research positions over 19 years. Prior to this his experience includes 5 years at McKinsey & Co and 2 years at Cazenove. David has a PhD in Respiratory Pharmacology (Imperial College, Royal Brompton Hospital).

Amara Singh

Amara holds a degree in Biomedical Sciences from Kings College London. With experience in laboratory and front-line healthcare settings, she started her career as a healthcare equity analyst at Intron Health in 2020.

Maria Van Tonder

Maria Van Tonder

Maria joined New Street Research LLP in 2008 with the Pharmaceutical analyst team before taking on the role of Finance Director in 2011. Prior to joining NSR she worked in the Equity Research operations team at HSBC, having previously held roles in private equity M&A and equity research at UBS.